Cleared Traditional

K090603 - BARCO 5MP MAMMO, MODEL MDMG-5221

K090603 is an FDA 510(k) clearance for BARCO 5MP MAMMO, manufactured by Barco N.V.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 48-day FDA review.

K090603 · Barco N.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2009
Decision
48d
Days
Class 2
Risk

K090603 is an FDA 510(k) clearance for the BARCO 5MP MAMMO, MODEL MDMG-5221. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Barco N.V. (Beaverton, US). The FDA issued a Cleared decision on April 22, 2009 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Barco N.V. devices

FDA 510(k) Submission Details - K090603

510(k) Number K090603 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 05, 2009
Decision Date April 22, 2009
Days to Decision 48 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 107d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1940
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K090603.
SYNGOCIRCULATION DYNAMICPET, VERSION 1.0
K083327 · Siemens Medical Solutions USA, Inc. · May 2009
SYNGO US WORKPLACE
K091286 · Siemens Medical Solutions USA, Inc. · May 2009
NIO 2MP (MDNG-2121)
K091172 · Barco N.V. · May 2009
BLUE SKY BIO PLAN, VERSION .38
K090607 · Blue Sky Bio, LLC · Apr 2009
NIO COLOR 3MP AND MDNC-3121
K090732 · Barco N.V. · Apr 2009
BRIT PACS SYSTEMS
K081168 · Brit Systems, Inc. · Mar 2009